Biopolym. Cell. 1990; 6(1):67-73.
Comparative studies in expression of model bacterial β-galactosidase gene in culture of murine fibroblasts and during direct injection into the animal liver
- Institute of Molecular Biology and Genetics, Academy of Sciences of the Ukrainian SSR
Kiev, USSR
Abstract
A vehicle with a model gene of the bacterial b-galactosidase has been constructed on the basis of DNA of hepatitis B virus. Comparative studies in the expression of E. coli lacZ gene under the control of promoters of hepatitis B virus and early promoter of SV40 virus in culture of murine fibroblasts (Ltk- cells) and in murine liver cells with immediate introduction of genetic material into liver by injection as part of liposomes have been conducted. The bacterial β-galactosidase gene under the control of promoter of surface antigen hepatitis B virus gene has been expressed much more efficiently in these cells
Full text: (PDF, in Russian)
References
[1]
Neborachko LN, Lukash LL, Troyanovsky BM, Varzanova IS, Buzhievskaya TI, Kordium VA. Studies in possibility of expression of exogenic human insulin gene in cultured mammalian fibroblasts. Biopolym Cell. 1989; 5(2):58-61.
[2]
Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52(2):456-67.
[3]
Kostetsky IE, Shpilevaya SP, Likhacheva LI, Zharova LC, Irodov DM, Kirillova VS, Kordium VA. Expression of Escherichia coli?-Galactosidase in murine hepatocytes. Biopolym Cell. 1989; 5(2):51-8.
[4]
Chang HK, Chou CK, Chang C, Su TS, Hu C, Yoshida M, Ting LP. The enhancer sequence of human hepatitis B virus can enhance the activity of its surface gene promoter. Nucleic Acids Res. 1987;15(5):2261-8.
[5]
Vannice JL, Levinson AD. Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity. J Virol. 1988;62(4):1305-13.
[6]
Kozlovskaia TM, Pumpen PP. Structure and expression of human hepatitis B virus surface antigen. Mol Biol (Mosk). 1986;20(4):884-901.
[7]
Jameel S, Siddiqui A. The human hepatitis B virus enhancer requires trans-acting cellular factor(s) for activity. Mol Cell Biol. 1986;6(2):710-5.